Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- PMID: 18272812
- DOI: 10.1182/blood-2007-07-099226
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Abstract
The induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) is an important immune-evading mechanism used by tumors. However, the exact nature and function of MDSCs remain elusive, especially because they constitute a heterogeneous population that has not yet been clearly defined. Here, we identified 2 distinct MDSC subfractions with clear morphologic, molecular, and functional differences. These fractions consisted of either mononuclear cells (MO-MDSCs), resembling inflammatory monocytes, or low-density polymorphonuclear cells (PMN-MDSCs), akin to immature neutrophils. Interestingly, both MO-MDSCs and PMN-MDSCs suppressed antigen-specific T-cell responses, albeit using distinct effector molecules and signaling pathways. Blocking IFN-gamma or disrupting STAT1 partially impaired suppression by MO-MDSCs, for which nitric oxide (NO) was one of the mediators. In contrast, while IFN-gamma was strictly required for the suppressor function of PMN-MDSCs, this did not rely on STAT1 signaling or NO production. Finally, MO-MDSCs were shown to be potential precursors of highly antiproliferative NO-producing mature macrophages. However, distinct tumors differentially regulated this inherent MO-MDSC differentiation program, indicating that this phenomenon was tumor driven. Overall, our data refine tumor-induced MDSC functions by uncovering mechanistically distinct MDSC subpopulations, potentially relevant for MDSC-targeted therapies.
Similar articles
-
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.Eur J Immunol. 2013 Nov;43(11):2930-42. doi: 10.1002/eji.201343349. Epub 2013 Aug 25. Eur J Immunol. 2013. PMID: 23878002
-
Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.Eur J Immunol. 2009 Oct;39(10):2865-76. doi: 10.1002/eji.200939486. Eur J Immunol. 2009. PMID: 19637228
-
IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.Eur J Immunol. 2014 Aug;44(8):2457-67. doi: 10.1002/eji.201444497. Epub 2014 Jun 16. Eur J Immunol. 2014. PMID: 24810636 Free PMC article.
-
Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis.Front Immunol. 2018 Dec 4;9:2849. doi: 10.3389/fimmu.2018.02849. eCollection 2018. Front Immunol. 2018. PMID: 30564242 Free PMC article. Review.
-
Myeloid-Derived Suppressor Cells in Trypanosoma cruzi Infection.Front Cell Infect Microbiol. 2021 Aug 27;11:737364. doi: 10.3389/fcimb.2021.737364. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34513737 Free PMC article. Review.
Cited by
-
Myeloid-derived suppressor cells in cancer and cancer therapy.Nat Rev Clin Oncol. 2024 Feb;21(2):147-164. doi: 10.1038/s41571-023-00846-y. Epub 2024 Jan 8. Nat Rev Clin Oncol. 2024. PMID: 38191922 Review.
-
Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing mice.J Transl Med. 2012 Jul 30;10:152. doi: 10.1186/1479-5876-10-152. J Transl Med. 2012. PMID: 22846631 Free PMC article.
-
New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.Cells. 2021 Apr 14;10(4):893. doi: 10.3390/cells10040893. Cells. 2021. PMID: 33919732 Free PMC article. Review.
-
The impact of the myeloid response to radiation therapy.Clin Dev Immunol. 2013;2013:281958. doi: 10.1155/2013/281958. Epub 2013 Apr 7. Clin Dev Immunol. 2013. PMID: 23653658 Free PMC article. Review.
-
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy.Theranostics. 2022 Aug 29;12(14):6273-6290. doi: 10.7150/thno.76854. eCollection 2022. Theranostics. 2022. PMID: 36168626 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous